APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Subscribe to see Apt Medical Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Apt Medical Inc. is a healthcare company headquartered in Shenzhen, China. It is publicly listed (688617) with a market capitalisation of $5.1B. Xcout tracks 1 named person at Apt Medical Inc., including Cheng Zhenghui (President).
A few of Apt Medical Inc.'s closest competitors — see the full list of competitors and alternatives →
Shanghai HeartCare Medical Technology Corporation Limited is a global enterprise specializing in the research, development, manufacturing, and commercialization of neuro-interventional medical devices. Its extensive product range encompasses devices for ischemic stroke thrombectomy, intracranial stenosis intervention, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access. These medical technologies are utilized for both the prevention and treatment of ischemic stroke, including acute ischemic events and intracranial narrowing, as well as for addressing hemorrhagic stroke. Established in 2016 and previously operating as Shanghai Care Medical Technology Corporation Limited, the company maintains its headquarters in Shanghai, People's Republic of China.
CathVision is a medical technology company founded in 2013 and headquartered in Copenhagen, Denmark, specializing in electrophysiology (EP) recording technologies and developer of the FDA-cleared ECGenius System.
Ablative Solutions, Inc. is a medical device company headquartered in San Jose, California. Founded to address unmet clinical needs in the treatment of hypertension, the company develops interventional therapeutic devices.
Advanced Particle Therapy develops, builds, and manages proton therapy cancer treatment centers for academic medical institutions and healthcare systems. The company provides turnkey development solutions, including facility design and construction, equipment planning, financing, and operational management.
Ichor Vascular, Inc. is a medical device company developing advanced arterial and venous solutions to bridge clinical gaps in thrombectomy technologies. Headquartered in Boca Raton, Florida, the firm innovates surgical tools for vascular treatments.
Cordis is an international medical device company that develops, manufactures, and markets cardiovascular and endovascular devices for diagnostics and interventional procedures to treat coronary and peripheral vascular diseases. Headquartered in Miami Lakes, Florida, the company operates in more than 70 countries and employes over 4,000 people worldwide.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.